Video Experimental Relacionado
Updated: Jun 24, 2025
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.0K
Definición del transcriptoma dependiente de KRAS y ERK en cánceres mutantes de KRAS
Jeffrey A Klomp1,2, Jennifer E Klomp1, Clint A Stalnecker1,2
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Science (New York, N.Y.)
|June 6, 2024
Resumen
El oncogén KRAS impulsa el crecimiento del cáncer, pero sus mecanismos no están claros. Nuestro estudio revela que la señalización ERK es clave para el crecimiento del cáncer mutante KRAS y la resistencia a las terapias dirigidas.
Área de la Ciencia:
- En el campo de la oncología
- Biología molecular
- Genética del cáncer
Sus antecedentes:
- El oncogén KRAS es un factor clave de varios cánceres, pero los mecanismos moleculares precisos que subyacen a su actividad oncogénica y la resistencia terapéutica asociada siguen siendo incompletamente entendidos.
- Comprender la transcripción genética impulsada por KRAS es crucial para desarrollar tratamientos efectivos contra el cáncer.
Objetivo del estudio:
- Para establecer un retrato transcripcional de todo el sistema de KRAS y la dependencia de la quinasas reguladas por la señal extracelular (ERK) en los cánceres mutantes de KRAS.
- Para delinear los mecanismos moleculares que impulsan el crecimiento del cáncer y la resistencia al inhibidor.
- Identificar las vías clave reguladas por la señalización de ERK en los cánceres mutantes KRAS.
Principales métodos:
- Perfiles de transcripción génica en todo el sistema en modelos de cáncer con mutantes KRAS.
- Integración de los datos transcriptómicos con el análisis proteómico (fosfoproteoma y proteoma total).
- Análisis de la actividad en cascada de la proteína quinasa activada por mitógeno ERK (MAPK).
Principales resultados:
- Se identificó una nueva firma genética dependiente de KRAS, distinta de las firmas informadas anteriormente.
- La transcripción impulsada por KRAS está mediada predominantemente por la cascada ERK MAPK.
- La desregulación de ERK del complejo/ciclosoma promotor de la anafase (APC/C) y el mecanismo del ciclo celular se destacó como crítico para el crecimiento del adenocarcinoma ductal pancreático (PDAC).
Conclusiones:
- La señalización de ERK juega un papel mecánico crítico en el crecimiento del tumor mutante KRAS.
- La señalización de ERK está implicada en la resistencia a las terapias dirigidas a KRAS-ERK MAPK.
- Este estudio proporciona nuevos conocimientos sobre la oncogénesis impulsada por KRAS y posibles estrategias terapéuticas.
Videos de Conceptos Relacionados
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:07MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K